CompletedNot Applicable

Effects of OCTA-guided PDT in Acute CSC

China23 participantsStarted 2017-09-01

Plain-language summary

OCTA-guided PDT is as safe and effective as ICGA-guided PDT in the treatment of acute central serous chorioretinopathy. Or OCTA-guided PDT is more effective than ICGA-guided PDT in the treatment of acute central serous chorioretinopathy, safe as well.

Who can participate

Age range18 Years – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Idiopathic detachment of the neurosensory retina with a focal leak at the level of the RPE with FA * Presence of SRF and/or serous pigment epithelial detachment on OCT * Presence of abnormal dilated choroidal vasculature in ICGA Exclusion Criteria: * Patients with other ocular conditions commonly associated with SRF, such as choroidal neovascularization, polypoidal choroidal vasculopathy (PCV), diabetic retinopathy, retinal vascular occlusion, Coat's disease * Any disease that may affect the quality of imaging (quality of OCTA images \< 6), such as cataract, high myopia or nystagmus * History of ocular surgeries including retinal laser * Pregnancy * Any uncontrolled systemic disease * Any condition rendering patients intolerable to image acquisition

What they're measuring

Number of patients with subretinal fluid resolution on OCT after PDT of two groups

Timeframe: 3 months

Trial details

NCT IDNCT03497000

SponsorPeking University People's Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2017-12-01

View on ClinicalTrials.gov More Central Serous Chorioretinopathy trials